在整合蛋白β1D缺陷中介的RyR2功能障碍有助于在心律失常性右心室肌肉病症中对catecholamine敏感的心动节拍
Yihui Wang1, Chunyan Li1, Ling Shi2
1State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (Y.W., C.L., X.C., C.C., M.L., S.Z.).
Circulation
|March 4, 2020
概括
整体蛋白β1D缺乏是导致心律失常的右心室肌肉病 (ARVC) 的新病因. 这项研究揭示了一种新的机制,将德斯莫普拉金损失与整合蛋白β1D缺乏联系起来,从而增加心脏突然死亡的风险.
科学领域:
- 心脏病学
- 分子生物学
- 遗传学
背景情况:
- 节律失常右心室肌病 (ARVC) 是一种遗传性心脏病,导致心律失常和心脏突然死亡.
- 目前的ARVC治疗旨在减轻症状并预防心脏突然死亡,但潜在的心律失常机制尚不清楚.
研究的目的:
- 研究整合蛋白β1D在ARVC病变中的作用.
- 阐明在ARVC中将整合素β1D缺乏与心律失常联系在一起的分子机制.
主要方法:
- 蛋白质质谱检测在ARVC心脏中发现了降调的整合蛋白β1.
- 为功能和生化分析生成心脏特异性β1D淘汰小鼠.
- 采用西式涂抹,双层脂质补丁,以及体内/体外研究.
主要成果:
- 在ARVC患者的心脏中发现了整合蛋白β1D缺乏和RyR2过.
- 整体蛋白β1D稳定了RyR2功能;其缺乏增加了RyR2开放的可能性.
- 乙1D绝杀小鼠表现出与RyR2高酸化和异常的Ca2+处理相关的对甲醇胺敏感的心室低心率.
- 通过ERK1/ 2- 纤维素- 无素/ 溶酶体途径诱导德斯莫普拉金缺乏.
结论:
- 整体蛋白β1D缺乏是导致ARVC腹腔失常的新机制.
- 这一发现为ARVC病理生理学和潜在的治疗点提供了新的见解.
相关概念视频
Mechanism of Cardiac Arrhythmias
1.5K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy
380
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
380
Cardiomyopathy I: Introduction and Classification
423
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
423
Disturbances in Heart Rhythm
2.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.3K
Dysrhythmias IV: Characteristics of Bradyarrhythmias
386
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
386
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.3K


